INNT
TOTAL INVALIDATION PROCESSED BY THE IB
24/10/2025
Voltar para busca
Dado oficial do USPTO
KIOMED
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
25/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42, 44
Data de depósito
29/09/2016
Data de registro
13/03/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2024
Última transação
25/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
BE
Examinador
MIDDLETON,BERNICE L
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
KiOmed Pharma, Société Anonyme
Representantes
Dmitriy O. Makarov IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalschitosanchitinchitosan derivatives; chemicalschitin derivatives; chemical products for use in industry or science; chemical additives for manufacture of pharmaceutical productsvaccines and cosmetics; active chemical ingredients used in the manufacture of pharmaceutical products for treating musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally
Classe 5
Pharmaceutical preparations for the treatment and prevention of musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; veterinary preparations for the treatment and prevention of musculo-sketletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally in farm animals and domestic pets; sanitary products for medical purposes; dietetic food and substanceswheat-free and gluten-free pastacrakersbread to accommodate special medical and health conditionsdietetic sugar and infusion adapted for medical or veterinary use; materials for medical dressings; material for dental fillings and dental impressions; disinfectants for hygienic purposesdisinfectants for sanitary purposesdisinfectants for medical instruments; bath preparations for medical use; chemical preparations for medical or pharmaceutical use for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; pharmaceutical products based on materials of plant origin for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; pharmaceutical products based on chitosanchitinchitosan derivatives of vegetable originchitin derivatives for the treatment and prevention of musculoskeletal disordersdermal volumizing and dermatological disorderseye disorder or eye tissue regenerationacute and chronic diseases by achieving sustained and targeted delivery of the activelocallyintravenously or orally; vaccines; preparations for vaccines
Classe 10
Surgicalmedicaldental and veterinary apparatus and instrumentsvertebral osteosynthesis staple-shaped apparatus and instrumentsdevices used in orthopedic surgery to position surgical instrumentsimplants and/or patients' limbsorthopedic fixation device used in orthopedic transplant and/or implant surgerysurgical and medical apparatus and instruments for use in spinalgeneralorthopedic surgery; artificial limbseyes and teeth; orthopedic articlesnamely orthopedic cushions and bracessuture material; bonejointhip and breast prosthesesstaple-shaped prostheses for the spinal columnstaple-shaped prostheses of vertebral discs; artificial implantsnamely to fill joints and bonesto fill the dermis and other conjunctival tissuesartificial implants to be used as surgical aids
Classe 42
Scientific servicesnamely researchtestinganalysis and development services in the fields of medicinepharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology; design and development of medical technologies; conducting clinical trials and preliminary evaluations for othersparticularly for pharmaceutical products; evaluation of pharmaceutical products; scientific research and development services relating to vaccines and medicines; scientific researchanalysis and development services in chemistrybiochemistrybiologybiotechnology or bacteriology; scientific researchanalysis and development services in cosmetology; basic scientific research and clinical research in the fields of sciencenamely clinical trials and medicine; scientific researchtesting and development of products developed using materials of vegetable origin; scientific researchtesting and development of products developed using chitosanchitinchitosan derivatives of vegetable originchitin derivatives; carrying out technical or scientific studies in the fields of medicinepharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology; provision of information and a database relating to scientific and medical research and development in the field of pharmaceutical productschemistrybiochemistrybiologybiotechnology or bacteriology
Classe 44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical assistance; cosmetic surgery; hospital services; nursing homes; convalescence or rest homes; opticians' services; alternative medicine services; health counseling services; medical equipment rental; telemedicine services; therapeutic servicesnamely therapeutic radiological services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/10/2025
INPC
INVALIDATION PROCESSED
02/10/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
27/05/2025
C71T
CANCELLED SECTION 71
27/09/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/07/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/06/2018
FIMP
FINAL DISPOSITION PROCESSED
19/06/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
13/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/12/2017
PUBO
PUBLISHED FOR OPPOSITION
26/12/2017
GPNX
NOTIFICATION PROCESSED BY IB
22/12/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2017
RFNT
REFUSAL PROCESSED BY IB
09/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2017
RFRR
REFUSAL PROCESSED BY MPU
23/03/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/03/2017
CNRT
NON-FINAL ACTION WRITTEN
21/03/2017
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2017
DOCK
ASSIGNED TO EXAMINER
17/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KIOMED ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.